1. Home
  2. PPTA vs SUPN Comparison

PPTA vs SUPN Comparison

Compare PPTA & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perpetua Resources Corp.

PPTA

Perpetua Resources Corp.

HOLD

Current Price

$25.66

Market Cap

2.9B

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$45.79

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PPTA
SUPN
Founded
2011
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.6B
IPO Year
N/A
2012

Fundamental Metrics

Financial Performance
Metric
PPTA
SUPN
Price
$25.66
$45.79
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
4
Target Price
$25.38
$63.25
AVG Volume (30 Days)
2.6M
767.4K
Earning Date
11-17-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$681,539,000.00
Revenue This Year
N/A
$8.32
Revenue Next Year
N/A
$23.36
P/E Ratio
N/A
N/A
Revenue Growth
N/A
4.54
52 Week Low
$7.81
$29.16
52 Week High
$31.65
$57.65

Technical Indicators

Market Signals
Indicator
PPTA
SUPN
Relative Strength Index (RSI) 58.94 46.31
Support Level $24.26 $44.09
Resistance Level $26.68 $47.00
Average True Range (ATR) 1.54 1.25
MACD 0.24 0.10
Stochastic Oscillator 81.27 57.97

Price Performance

Historical Comparison
PPTA
SUPN

About PPTA Perpetua Resources Corp.

Perpetua Resources Corp is focused on the exploration, site restoration, and redevelopment of gold-antimony-silver deposits in the Stibnite-Yellow Pine district of central Idaho that are encompassed by the Stibnite Gold Project. The Project is one of the highest-grade, open-pit gold deposits in the United States and is designed to apply a modern, responsible mining approach to restore an abandoned mine site and produce both gold and the only mined source of antimony in the United States. It has one segment, mineral exploration in the United States.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: